FLUORESCENT DIAGNOSTICS OF MALIGNANT SKIN TUMORS WITH CHLORIN SERIES PHOTOSENSITIZERS
https://doi.org/10.24931/2413-9432-2018-7-1-13-20
Abstract
The article shows possibilities in fluorescence imaging of malignant skin tumors with chlorin series photosensitizers (PS) photolon and fotoditazin. The regularities of photosensitizer accumulation from the data of local fluorescence spectroscopy depending on the PS and its dose, the clinical picture and the histological form of the malignant skin neoplasm is investigated. It is shown that the level and selectivity of PS accumulation in the tumor focus depends on the PS dose. In studies on 10 patients with basal cell skin cancer after the introduction of fotoditazin at a dose less than 1 mg/kg, fluorescent contrast between tumor and healthy tissue varied between 1.3 and 9.5, the average was 2.8±0.3; for patients who had the administered fotoditazin dose of 1 mg/kg, fluorescent contrast was 2.9±0.4, varying from 1.4 to 5. In a study with 127 patients after the introduction of photolon in the dose of 0.7-1 mg/kg, the average value of the fluorescence intensity in relative units in the intact skin was 6.9±0.3 (min 4.6, max 12.2), at a dose of 1.1 to 1.4 mg/kg – 8.0±0.3 (min 4.6, max 12.5), at a dose of 1.5-2 mg/kg – 9.9±0.7 (min 5.7, max 20.3). It is also shown that fluorescence intensity of malignant neoplasm of the skin with the same dose of the photosensitizer depends on the neoplasm’s clinical and histological forms. So, 3 hours after the introduction of photolon at a dose of 1.3 mg/kg the average fluorescent contrast in the surface type of skin cancer was 2.7±0.5, in the nodal form – 2.3±0.2, in erosive-ulcerative form – 3.6±0.3. In patients with nodular form of squamous skin cancer after the introduction of photolon at a dose of 1.3 mg/kg fluorescent contrast was significantly higher (p<0.05) (average of 2.8±0.2) than in the nodular form of basal cell carcinoma after the introduction of photolon at the same dose (average of 2.1±0.2).
About the Authors
E. V. Yaroslavtseva-IsaevaRussian Federation
Moscow
M. A. Kaplan
Russian Federation
Moscow
V. N. Kapinus
Russian Federation
Moscow
I. S. Spichencova
Russian Federation
Moscow
N. I. Sokol
Russian Federation
Moscow
References
1. Aleksandrov M.T. Lazernaya klinicheskaya biofotometriya (teoriya, eksperiment, praktika) [Laser clinical biophotometry (theory, experiment, practice)]. Мoscow, Tekhnosfera Publ., 2008. 584 p.
2. Lakovich Dzh. Osnovy fluorestsentnoi spektroskopii [Fundamentals of fluorescence spectroscopy]. Мoscow, Mir Publ., 1986. 496 p.
3. Gorenkov R.V., Karpov V.N, Rogatkin D.A., Shumskii V.I. Chronic hypoxia as one of the factors of increased fluorescence of endogenous porphyrins in living biological tissues, Biophizika, 2007, Vol. 52, No. 4, pp. 711-717. (in Russian)
4. Rogatkin D.A., Bychenkov O.A., Polyakov P.Yu. Noninvasive spectrophotometry in modern radiology: accuracy and informativity of measurement results, Al'manakh klinicheskoi meditsiny, 2008, Vol. 17-1, pp. 83-87. (in Russian)
5. Schor N. Correlation between autofluorescence intensity and tumor area in mice bearing renal cell carcinoma, J Fluoresc, 2008, No. 18(6), pp. 1163-1168.
6. Dronova O.B., Tret'yakov A.A., Mishchenko A.N., Bulgakova N.N. Study of the possibilities of laser-induced fluorescence in the diagnosis of Barrett's esophagus, Sibirskii onkologicheskii zhurnal, 2008, No. 4, pp. 11-12. (in Russian)
7. Loshchenov V.B., Lin'kov K.G., Savel'eva T.A., Loshchenov M.V., Model' S.S., Borodkin A.V. Hardware and tool equipment for fluorescence diagnostics and photodynamic therapy, Biomedical photonics, 2013, No. 3, pp. 17-25. (in Russian)
8. Sokolov V.V., Rusakov I.G., Bulgakova N.N., Ul'yanov R.V., Teplov A.A. Fluorescent techniques in the diagnosis of superficial bladder cancer (review), Sibirskii onkologicheskii zhurnal, 2007, No. 4, pp. 117-126. (in Russian)
9. Chissov V.I., Sokolov V.V., Bulgakova N.N., Filonenko E.V. Fluorescent endoscopy, dermatoscopy, spectrophotometry in the diagnosis of malignant tumors of the main localizations, Rossiiskii bioterapevticheskii zhurnal, 2003, Vol. 5, No. 4, pp. 42-56.
10. Filonenko E.V, Loshchenov V.B., Sotnikov V.N., Razzhivina A.A., Perevoznikov A.I., Savel'eva T.A., Radvanskaya O.A., Sokolov A.A., Ageikina N.V. Autofluorescent diagnostics in patients with epithelial neoplasms of the colon, Sibirskii onkologicheskii zhurnal, 2010, No. 5, pp. 17-21. (in Russian)
11. Rotomskis R., Streckyte G. Fluorescence diagnostics of tumors, Medicina (Kaunas), 2004, 40(12), pp. 1219-1230. (in Lithuanian)
12. Zhao J., Lui H., McLean D.I., Zeng H. Real-time raman spectroscopy for non-invasive skin cancer detection – preliminary results, ConfProc IEEE Eng Med Biol Soc, 2008, 2008, pp. 3107-3109. doi: 10.1109/IEMBS.2008.4649861
13. Moan J., Bech O., Peng Q., Berg K. Use of 5-aminolevulinic acid in photochemotherapy and fluorescence diagnostics, Tidsskr Nor Laegeforen, 1998, 118(8), pp. 1206-1211.
14. Gamayunov S.V., Korchagina K.S., Skrebtsova R.R., Karov V.A. Exploring the possibility of fluorescent monitoring of PDT in clinic, Sibirskii onkologicheskii zhurnal, 2015, No. S1, p. 24. (in Russian)
Review
For citations:
Yaroslavtseva-Isaeva E.V., Kaplan M.A., Kapinus V.N., Spichencova I.S., Sokol N.I. FLUORESCENT DIAGNOSTICS OF MALIGNANT SKIN TUMORS WITH CHLORIN SERIES PHOTOSENSITIZERS. Biomedical Photonics. 2018;7(1):13-20. (In Russ.) https://doi.org/10.24931/2413-9432-2018-7-1-13-20